Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Gayle C. Blouin"'
Autor:
Hope S. Rugo, Elene Viscosi, Gayle C. Blouin, Aditya Bardia, Jennifer Hutchinson, Colin D. Weekes, Beverly Moy, Erika Nakajima, Laura Spring
Publikováno v:
Oncologist
Patients with metastatic triple-negative breast cancer have a poor prognosis. Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate that contains the irinotecan active metabolite, SN-38, linked to a humanized monoclonal antibody targeting tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0521ca9c7332dd1eddb4d3a341d0792
https://doi.org/10.1002/onco.13878
https://doi.org/10.1002/onco.13878
Publikováno v:
Journal of Clinical Oncology. 40:50-50
50 Background: Educating staff on new anticancer medications is imperative for patient safety. Infusion nurses at Dana Farber Cancer Institute (DFCI) satellite infusion centers were surveyed on their comfort level administering newer oncology drugs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dddb83aec3514ce6ef30323f4b8d94ac
https://doi.org/10.1200/jco.2022.40.28_suppl.050
https://doi.org/10.1200/jco.2022.40.28_suppl.050
Autor:
Aaron Cheng, Erica Tavares, Yevgeniy R. Semenov, Jennifer Hutchinson, Kerry L. Reynolds, Monica A Jackson, Meghan J. Mooradian, Mia Bothwell, Gayle C. Blouin, Leyre Zubiri, Leila Rostamnjad
Publikováno v:
Journal of Clinical Oncology. 39:2655-2655
2655 Background: Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer with significantly improved outcomes, but these agents have a unique spectrum of toxicities known as immune-related adverse events (irAEs). The recommend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2befcb937e0f2a30125c4687e7e8801e
https://doi.org/10.1200/jco.2021.39.15_suppl.2655
https://doi.org/10.1200/jco.2021.39.15_suppl.2655
Autor:
Randy Taplitz, Lindsey R. Baden, John W. Wilson, Alison G. Freifeld, Sankar Swaminathan, Shmuel Shoham, Karin G. Hoffmann, John N. Greene, Corey Casper, Brahm H. Segal, Ashley Morris Engemann, Jeffrey Topal, Daniel R. Kaul, Bernard C Camins, James I. Ito, Susan K. Seo, Gayle C. Blouin, Jose G. Montoya, Courtney Smith, Kenneth V. I. Rolston, Mark E. Lustberg, Erik R. Dubberke, Brenda W. Cooper, Gowri Satyanarayana, Michael Angarone
Publikováno v:
Journal of the National Comprehensive Cancer Network. 14:882-913
Infectious diseases are important causes of morbidity and mortality in patients with cancer. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and Treatment of Cancer-Related Infections characterize the major pathogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21186aaa677418cb3e42fe6ba5a963d5
https://doi.org/10.6004/jnccn.2016.0093
https://doi.org/10.6004/jnccn.2016.0093
Autor:
Margaret Ruddy, Areej El-Jawahri, E. Bridget Kim, Jennifer S. Temel, Christine Chio, Daniel E. Lage, Ryan D. Nipp, Joseph A. Greer, David P. Ryan, Ying Long, Gayle C. Blouin, Barbara Kong Mui Li, Charn-Xin Fuh, Mark L. Zangardi
Publikováno v:
The oncologist. 24(2)
Background Oncology clinicians often struggle with managing medications and vaccinations in older adults with cancer. We sought to demonstrate the feasibility and preliminary efficacy of integrating pharmacists into the care of older adults with canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c12a7a14a7803a1c77c950439068ade2
https://pubmed.ncbi.nlm.nih.gov/30341175
https://pubmed.ncbi.nlm.nih.gov/30341175
Introduction: The introduction of CDK4/6 inhibitors, such as ribociclib, has changed the treatment landscape for post-menopausal women with HR+/HER2- advanced or metastatic breast cancer. As first-line treatment of HR+/HER2- MBC, the addition of a CD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b7896a345867cbfec3e1f22ef43d9a7
Publikováno v:
American Journal of Health-System Pharmacy. 71:500-506
Palonosetron, a serotonin type 3–receptor (5-HT3) antagonist, was approved by the Food and Drug Administration (FDA) in 2003 for the prevention of acute chemotherapy-induced nausea and vomiting (CINV) associated with initial and repeat courses of h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04ff4d070b953fdee486235e8b015aae
https://doi.org/10.2146/ajhp130394
https://doi.org/10.2146/ajhp130394
Autor:
Leila Rostamnjad, Gayle C. Blouin, Laura F. White, Mark L. Zangardi, Ryan D. Nipp, Mimi Bartholomay, E. Bridget Kim
Publikováno v:
Journal of Clinical Oncology. 37:71-71
71 Background: Annual influenza vaccination is recommended for individuals 6 months and older. Older adults are at high-risk of developing influenza and complications associated with the virus. However, < 50% of patients with cancer receive the influ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7abd18b8d52d958fdc3555a0149e3beb
https://doi.org/10.1200/jco.2019.37.27_suppl.71
https://doi.org/10.1200/jco.2019.37.27_suppl.71
Autor:
Gayle C. Blouin, Pamela Connolly, Kelly Goodwin, Julie Zydel, Jennifer S. Temel, Leila Rostamnjad
Publikováno v:
Journal of Clinical Oncology. 36:61-61
61 Background: National Comprehensive Cancer Network recommends pneumococcal vaccination for adults 19 years and older with cancer. Currently at Massachusetts General Hospital (MGH) pneumococcal vaccination is not part of routine cancer care. A vacci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e83485eabf60af9047356825c7377b47
https://doi.org/10.1200/jco.2018.36.30_suppl.61
https://doi.org/10.1200/jco.2018.36.30_suppl.61
Autor:
Gayle C. Blouin, Mark L. Zangardi, Areej El-Jawahri, Ryan D. Nipp, Daniel E. Lage, Barbara Kong Mui Li, E. Bridget Kim, Ying Long, Christine Chio, Margaret Ruddy, Jennifer S. Temel
Publikováno v:
Journal of Clinical Oncology. 36:10012-10012
10012Background: Oncology clinicians often struggle with managing medications and vaccinations in older adults with cancer. We sought to demonstrate the feasibility and preliminary efficacy of inte...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::029d618bd2640cf52fb246952ce4c59e
https://doi.org/10.1200/jco.2018.36.15_suppl.10012
https://doi.org/10.1200/jco.2018.36.15_suppl.10012